{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T21:23:39Z","timestamp":1787261019886,"version":"build-2736575974"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,8,5]],"date-time":"2027-08-05T00:00:00Z","timestamp":1817424000000},"content-version":"am","delay-in-days":277,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000050","name":"National Heart Lung and Blood Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Heart Journal"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.ahj.2026.107525","type":"journal-article","created":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T16:36:34Z","timestamp":1783528594000},"page":"107525","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Comparative effectiveness of torsemide vs furosemide in the management of heart failure patients: Win-ratio reanalysis of the TRANSFORM-HF trial"],"prefix":"10.1016","volume":"301","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7697-5029","authenticated-orcid":false,"given":"Guangyu","family":"Tong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukang","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen J.","family":"Greene","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin J.","family":"Anstrom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey","family":"Testani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert J.","family":"Mentz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric J.","family":"Velazquez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ahj.2026.107525_bib0001","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD003838.pub3","article-title":"Diuretics for heart failure","author":"Faris","year":"2012","journal-title":"Cochrane Datab System Rev"},{"key":"10.1016\/j.ahj.2026.107525_bib0002","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.1056\/NEJMra1703100","article-title":"Diuretic treatment in heart failure","volume":"377","author":"Ellison","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2026.107525_bib0003","article-title":"Diuretic changes, health care resource utilization, and clinical outcomes for heart failure with reduced ejection fraction: from the change the management of patients with heart failure registry","volume":"14","author":"Khan","year":"2021","journal-title":"Circ: Heart Fail"},{"key":"10.1016\/j.ahj.2026.107525_bib0004","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1016\/j.jacc.2012.12.043","article-title":"Dominance of Furosemide for loop diuretic therapy in heart failure","volume":"61","author":"Bikdeli","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2026.107525_bib0005","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.ahj.2014.12.009","article-title":"A reappraisal of loop diuretic choice in heart failure patients","volume":"169","author":"Buggey","year":"2015","journal-title":"Am Heart J"},{"key":"10.1016\/j.ahj.2026.107525_bib0006","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1080\/14779072.2022.2022474","article-title":"An evaluation of torsemide in patients with heart failure and renal disease","volume":"20","author":"Peters","year":"2022","journal-title":"Expert Rev Cardiovasc Ther"},{"key":"10.1016\/j.ahj.2026.107525_bib0007","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1001\/jama.2022.23924","article-title":"Effect of torsemide vs furosemide after discharge on all-cause mortality in patients hospitalized with heart failure: the TRANSFORM-HF randomized clinical trial","volume":"329","author":"Mentz","year":"2023","journal-title":"JAMA"},{"key":"10.1016\/j.ahj.2026.107525_bib0008","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1161\/CIRCULATIONAHA.123.064842","article-title":"Effect of torsemide versus furosemide on symptoms and quality of life among patients hospitalized for heart failure: the TRANSFORM-HF randomized clinical trial","volume":"148","author":"Greene","year":"2023","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2026.107525_bib0009","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.amjcard.2023.08.079","article-title":"Effect of furosemide versus torsemide on hospitalizations and mortality in patients with heart failure: a meta-analysis of randomized controlled trials","volume":"206","author":"Singh","year":"2023","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ahj.2026.107525_bib0010","first-page":"1","article-title":"Torsemide vs. furosemide in congestive heart failure: a systematic-review and meta-analysis on mortality and rehospitalization","author":"Gudushauri","year":"2025","journal-title":"Acta Cardiologica"},{"key":"10.1016\/j.ahj.2026.107525_bib0011","article-title":"Clinical outcomes with furosemide versus torsemide in patients with heart failure: an updated systematic review and meta-analysis","volume":"48","author":"Siddiqi","year":"2023","journal-title":"Curr Probl Cardiol"},{"key":"10.1016\/j.ahj.2026.107525_bib0012","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1093\/eurheartj\/ehr352","article-title":"The win ratio: a new approach to the analysis of composite endpoints in clinical trials based on clinical priorities","volume":"33","author":"Pocock","year":"2012","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ahj.2026.107525_bib0013","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1002\/ejhf.2853","article-title":"The win ratio method in heart failure trials: lessons learnt from EMPULSE","volume":"25","author":"Pocock","year":"2023","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.ahj.2026.107525_bib0014","doi-asserted-by":"crossref","DOI":"10.1056\/EVIDoa2300042","article-title":"Use of win statistics to analyze outcomes in the DAPA-HF and DELIVER trials","volume":"2","author":"Kondo","year":"2023","journal-title":"NEJM Evidence"},{"key":"10.1016\/j.ahj.2026.107525_bib0015","article-title":"Correlation matters! streamlining the sample size procedure with composite time-to-event endpoints","author":"Mou","year":"2025","journal-title":"arXiv"},{"key":"10.1016\/j.ahj.2026.107525_bib0016","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1080\/10543406.2020.1757692","article-title":"The inverse-probability-of-censoring weighting (IPCW) adjusted win ratio statistic: an unbiased estimator in the presence of independent censoring","volume":"30","author":"Dong","year":"2020","journal-title":"J Biopharmaceut Statist"},{"key":"10.1016\/j.ahj.2026.107525_bib0017","first-page":"325","article-title":"Pragmatic design of randomized clinical trials for heart failure","volume":"9","author":"Greene","year":"2021","journal-title":"JACC: Heart Fail"},{"key":"10.1016\/j.ahj.2026.107525_bib0018","doi-asserted-by":"crossref","first-page":"2379","DOI":"10.1016\/j.jacc.2020.09.542","article-title":"Interpreting the Kansas City cardiomyopathy questionnaire in clinical trials and clinical care","volume":"76","author":"Spertus","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2026.107525_bib0019","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1016\/S0735-1097(00)00531-3","article-title":"Development and evaluation of the Kansas City Cardiomyopathy Questionnaire: a new health status measure for heart failure","volume":"35","author":"Green","year":"2000","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2026.107525_bib0020","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1080\/10543406.2023.2275759","article-title":"Adjusted win ratio using the inverse probability of treatment weighting","volume":"35","author":"Wang","year":"2025","journal-title":"J Biopharmaceut Statist"},{"key":"10.1016\/j.ahj.2026.107525_bib0021","series-title":"Principles and practice of clinical trials","first-page":"1","article-title":"Missing data","author":"Tong","year":"2020"},{"key":"10.1016\/j.ahj.2026.107525_bib0022","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1177\/09622802221084134","article-title":"On recurrent-event win ratio","volume":"31","author":"Mao","year":"2022","journal-title":"Stat Methods Med Res"},{"key":"10.1016\/j.ahj.2026.107525_bib0023","series-title":"R: a language and environment for statistical computing","year":"2023"},{"key":"10.1016\/j.ahj.2026.107525_bib0024","author":"Cui"},{"key":"10.1016\/j.ahj.2026.107525_bib0025","first-page":"441","article-title":"Use of the win ratio in cardiovascular trials","volume":"8","author":"Ferreira","year":"2020","journal-title":"JACC: Heart Fail"},{"key":"10.1016\/j.ahj.2026.107525_bib0026","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1056\/NEJMoa1805689","article-title":"Tafamidis treatment for patients with transthyretin amyloid cardiomyopathy","volume":"379","author":"Maurer","year":"2018","journal-title":"N Engl J Med"}],"container-title":["American Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870326001870?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870326001870?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T20:25:36Z","timestamp":1787257536000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002870326001870"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":26,"alternative-id":["S0002870326001870"],"URL":"https:\/\/doi.org\/10.1016\/j.ahj.2026.107525","relation":{},"ISSN":["0002-8703"],"issn-type":[{"value":"0002-8703","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparative effectiveness of torsemide vs furosemide in the management of heart failure patients: Win-ratio reanalysis of the TRANSFORM-HF trial","name":"articletitle","label":"Article Title"},{"value":"American Heart Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ahj.2026.107525","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"107525"}}